PT Diagnos Laboratorium Utama Tbk

DGNS

ID1000158702

Healthcare Facilities & Services

End-of-day quote INDONESIA S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
252 ^IDR	-0.79%		-18.71%	+2.44%

04/03	PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

PT Diagnos Laboratorium Utama Tbk has filed an IPO.

December 14, 2020 at 10:30 am IST

PT Diagnos Laboratorium Utama Tbk has filed an IPO. Security Name: Common Shares Security Type: Common Stock Securities Offered: 250,000,000 Transaction Features: ESOP Related Offering

Latest news about PT Diagnos Laboratorium Utama Tbk

PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	04/03	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	31/23/31	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	03/23/03	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
Asa Ren Pte Ltd. announced that it has received $8.15 million in funding from Top Harvest Capital, Kejora Ventures, Marcy Venture Partners LLP, Northstar Advisors Pte. Ltd, Naya Capital Management UK Limited, PT Diagnos Laboratorium Utama Tbk, and others	09/23/09	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022	21/22/21	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Half Year Ended June 30, 2022	22/22/22	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022	18/22/18	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Full Year Ended December 31, 2021	05/22/05	CI
Pt Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Half Year Ended June 30, 2021	09/21/09	CI
PT Diagnos Laboratorium Utama Tbk has completed an IPO in the amount of IDR 50 billion.	15/21/15	CI
PT Diagnos Laboratorium Utama Tbk has filed an IPO.	14/20/14	CI

Chart PT Diagnos Laboratorium Utama Tbk

Duration

Period

More charts

PT Diagnos Laboratorium Utama Tbk is an Indonesia-based company that is engaged in providing health services using laboratories. The Companyâs scope of activities also includes private clinical activities. Its products and services include clinical pathology laboratory tests, anatomical pathology laboratory tests, genomics laboratory tests, homecare health tests, corporate health tests and Covid-19 tests. Its clinical pathology laboratory provides services ranging from molecular examinations to support more treatment. Its clinical pathology laboratory provides services for examination of hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology and microbiology. The services provided at the genetic laboratory are non-invasive prenatal testing (NIPT), preimplantation genetic testing for aneuploidy (PGT-A) services, and preimplantation genetic testing for monogenic diseases (PGT-M) services. Its homecare health services provide health checks that are done at home.

Sector

Healthcare Facilities & Services

Calendar

05/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
PT DIAGNOS LABORATORIUM UTAMA TBK	+2.44%	1.99Cr
SONIC HEALTHCARE LIMITED	-16.99%	867.4Cr
RADNET, INC.	+65.23%	425.4Cr
DR. LAL PATHLABS LIMITED	-1.10%	250.87Cr
SYNLAB AG	-10.68%	247.01Cr
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-41.76%	225.14Cr
NEOGENOMICS, INC.	-8.53%	191.44Cr
FLEURY S.A.	-19.29%	155.97Cr
DIAN DIAGNOSTICS GROUP CO.,LTD.	-39.61%	119.01Cr
METROPOLIS HEALTHCARE LIMITED	+9.54%	114.62Cr

Medical & Diagnostic Laboratories